Only 2 weeks after its official launch, Vella Bioscience the company behind Vella Women’s Pleasure Serum, a clinically demonstrated pre-play topical serum that promotes increased arousal and lubrication, and more frequent, intense, and satisfying orgasms, has closed a $7 million seed II funding round, anchored by Aaron Fleck & Associates. The oversubscribed funding round puts Vella Bioscience at over $50 million post-money valuation, positioning the company to move forward on…
![](https://femtechinsider.com/wp-content/uploads/2021/05/vella-womens-pleasure-serum-1-1000x658.jpeg)